Cargando…
Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: A case report
RATIONALE: The treatment of metastatic melanoma has been revolutionized in the past decade because of the development of immunotherapies and targeted therapies. Despite these developments, there is still an unmet clinical need for more advanced combination therapies for the subset of patients who re...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946408/ https://www.ncbi.nlm.nih.gov/pubmed/31689840 http://dx.doi.org/10.1097/MD.0000000000017769 |